Conference Coverage
Conference Coverage
Variations in blood cancer survival across Europe
chemotherapy Photo by Rhoda Baer VIENNA—Results of the EUROCARE-5 study have revealed regional differences in survival for European patients with...
Conference Coverage
mAb produces ‘encouraging’ results in MM
multiple myeloma ROME—Combination therapy incorporating a novel monoclonal antibody (mAb) can provide “encouraging, long-lasting tumor control”...
Conference Coverage
ECC: Nivolumab, Cabozantinib bring long overdue options to advanced kidney cancer
Nivolumab significantly extended overall survival in patients with advanced renal cell carcinoma.
Conference Coverage
ASCO: Many women with triple-negative breast cancer aren’t screened for BRCA
Many younger women diagnosed with triple-negative breast cancers do not get tested for BRCA, despite guideline recommendations.
Conference Coverage
Actionable mutations are highly prevalent in young lung cancer patients
Genomic testing is paramount when lung cancer occurs before age 40.
Conference Coverage
NLR correlates with survival in advanced breast cancer
Key clinical point: Neutrophil lymphocyte ratio (NLR) can be correlated with poor disease-specific survival in stage IV breast cancer and the...
Conference Coverage
Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patients
teaser
Conference Coverage
Abs from transplanted AML patients enhance GvL effect in vitro
NEW YORK—Investigators have found that B cells may play a role in stimulating graft-versus-leukemia (GvL) responses in patients with acute myeloid...
Conference Coverage
Insights from the 5-year follow-up of CTL019 in CLL
Photo courtesy of the University of Pennsylvania NEW YORK—The 5-year follow-up of the phase 1 trial of CTL019 in relapsed or refractory chronic...
Conference Coverage
Monitoring microbiome may help reduce infection in AML
Photo by Rhoda Baer SAN DIEGO—Monitoring the microbiome during chemotherapy might help reduce infections in leukemia patients, according to...
Conference Coverage
New assay may be a game changer in invasive candidiasis
The T2 magnetic resonance assay for rapid diagnosis or rule-out of invasive candidiasis has the potential to significantly change the management...